CLINICAL_TRIALS
trial_result
· 2021-04-09
Clinical Trial Update: Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model [Phase 1]
Summary
Phase 1 trial assessing safety, tolerability, and chemoprotective activity of P218 in a PfSPZ Challenge malaria model has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2021-04-09